Towards the Preparation of Smart Drug Delivery Platforms for Colorectal Cancer Therapy: Biocompatible and Targeted Mesoporous Silica Nanoparticles with Deferiprone-Copper Complex Gatekeeper DOI

Sonia Iranpour,

Khalil Abnous, Seyed Mohammad Taghdisi

и другие.

Опубликована: Янв. 1, 2024

Язык: Английский

Tumor-targeted delivery of SNHG15 siRNA using a ZIF-8 nanoplatform: Towards a more effective prostate cancer therapy DOI
Morvarid Saeinasab,

Sonia Iranpour,

Niloufar Hosseini-Giv

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 259, С. 129233 - 129233

Опубликована: Янв. 4, 2024

Язык: Английский

Процитировано

19

Advancing Cancer Therapy with Quantum Dots and Other Nanostructures: A Review of Drug Delivery Innovations, Applications, and Challenges DOI Open Access
Ashutosh Pareek,

Deepanjali Kumar,

Aaushi Pareek

и другие.

Cancers, Год журнала: 2025, Номер 17(5), С. 878 - 878

Опубликована: Март 4, 2025

Nanotechnology, particularly quantum dots (QDs), has ushered in a transformative era the pharmaceutical and medical industries, offering notable opportunities for nanoscale advancements. These particles, known their exceptional optical properties confinement, have emerged as indispensable tools cancer drug delivery bioimaging. This review delves into various conjugation techniques with QDs, including covalent linking, non-covalent conjugation, click chemistry, disulfide linkage, pH-sensitive linkage. Each method provides distinct advantages, such enhanced stability, reversibility, specificity, controlled release. Moreover, QDs demonstrated significant promise oncology by efficiently delivering drugs to cancerous tissues while minimising systemic toxicity. Investigations applications different cancers, blood, brain, cervical, breast etc., reveal efficacy targeted delivery, real-time imaging, improved therapeutic outcomes. However, challenges potential toxicity, pharmacokinetics, targeting specificity must be addressed fully harness benefits of therapy. Future research should focus on developing biocompatible optimising techniques, elucidating safety profiles long-term effects biological systems. Overall, represent promising frontier treatment, multifaceted capabilities that hold outcomes reduced side across cancers.

Язык: Английский

Процитировано

2

Enhanced theranostic efficacy of epirubicin-loaded SPION@MSN through co-delivery of an anti-miR-21-expressing plasmid and ZIF-8 hybridization to target colon adenocarcinoma DOI
Amir Abrishami, Ahmad Reza Bahrami, Amir Sh. Saljooghi

и другие.

Nanoscale, Год журнала: 2024, Номер 16(12), С. 6215 - 6240

Опубликована: Янв. 1, 2024

The SPION@MSN-EPI/pDNA-ZIF-8-PEG-Apt nanocarrier showcases exceptional plasmid stability, drug loading, and controlled release. Its outstanding anti-tumor efficacy through targeted chemo–gene therapy is supported by its imaging traceability.

Язык: Английский

Процитировано

14

Advancements in Colorectal Cancer Treatment: The Role of Metal-Based and Inorganic Nanoparticles in Modern Therapeutic Approaches DOI
Maryam Azarian, Marzieh Ramezani Farani, William C. Cho

и другие.

Pathology - Research and Practice, Год журнала: 2024, Номер 264, С. 155706 - 155706

Опубликована: Ноя. 6, 2024

Язык: Английский

Процитировано

9

Mapping the intellectual structure and emerging trends on nanomaterials in colorectal cancer: a bibliometric analysis from 2003 to 2024 DOI Creative Commons
Man Lu, Yi Liu,

Jin Zhu

и другие.

Frontiers in Oncology, Год журнала: 2025, Номер 14

Опубликована: Янв. 8, 2025

Colorectal cancer (CRC) is one of thes most prevalent malignant tumors worldwide. Current therapeutic strategies for CRC have limitations, while nanomaterials show significant potential diagnosing and treating CRC. This study utilizes bibliometric analysis to evaluate the current status trends in this field. Research on from 2003 2024 was retrieved Web Science Core Collection (WOSCC). Tools such as CiteSpace, VOSviewer, RStudio, GraphPad Prism, Excel were used analyze hotspots, covering publication trends, countries, institutions, authors, journals, co-citation analysis, keywords. Visual maps created forecast future developments. The includes 3,683 publications by 17,261 authors 3,721 institutions across 100 countries/regions, published 840 journals. Global steadily increased, particularly since 2018. China leads volume citations, with six top ten research seven cited United States excels citation impact academic centrality. Both countries currently dominate field, underscoring urgent need enhanced international collaboration. Ramezani M Abnous K lead H-index, Siegel RL highly cited. International Journal Nanomedicine has highest volume, Controlled Release In addition "colorectal cancer" "nanoparticles," common keyword "drug delivery." Emerging areas "metal-organic frameworks (MOFs)" "green synthesis" are gaining attention leading hotspots. offers an in-depth application CRC, promoting interdisciplinary collaboration advancing scientific progress

Язык: Английский

Процитировано

1

UiO-based platforms in biomedicine: Advanced nanovehicles for effective treatment DOI

Ren Zhang,

Abdulnasser Mahmoud Karami,

Qianying Huang

и другие.

Materials Today Chemistry, Год журнала: 2025, Номер 45, С. 102645 - 102645

Опубликована: Март 22, 2025

Язык: Английский

Процитировано

1

The utilization of metal-organic frameworks in tumor-targeted drug delivery systems DOI Creative Commons
Jiahui Kong, Mengru Cai,

Rongyue Zhu

и другие.

Journal of Science Advanced Materials and Devices, Год журнала: 2024, Номер 9(3), С. 100770 - 100770

Опубликована: Июль 23, 2024

Due to the non-specific distribution of drugs in body and low concentration at tumor site traditional chemotherapy, there are challenges associated with significant side effects resistance. Therefore, a drug delivery system (DDS) urgently needs be developed that can precisely target tumors. Metal-organic frameworks (MOFs) possess advantageous characteristics derived from organic inorganic materials, including small particle size, large specific surface area, high loading capacity, adjustable structure pore as well ease modification. Consequently, MOFs offer unique advantages for designing active targeting, passive stimulus-responsive targeting strategies have become hot topic current research on tumor-targeted systems. This review will elaborate application systems perspective different strategies. We hope this paper provide assistance therapy.

Язык: Английский

Процитировано

7

Application of dual chemotherapeutic drug delivery system based on metal-organic framework platform in enhancing tumor regression for breast cancer research DOI
Lin Zhan,

Xuelian Yin,

Li Qiu

и другие.

Biochemical and Biophysical Research Communications, Год журнала: 2024, Номер 710, С. 149889 - 149889

Опубликована: Апрель 4, 2024

Язык: Английский

Процитировано

4

Current landscape of metal–organic framework-mediated nucleic acid delivery and therapeutics DOI

Shi‐wei Feng,

Yan Li, Zheng Tan

и другие.

International Journal of Pharmaceutics, Год журнала: 2025, Номер unknown, С. 125295 - 125295

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Metal-organic framework nanoparticles activate cGAS-STING pathway to improve radiotherapy sensitivity DOI Creative Commons
Xinyao Hu, Hua Zhu, Yang Shen

и другие.

Journal of Nanobiotechnology, Год журнала: 2025, Номер 23(1)

Опубликована: Фев. 21, 2025

Tumor immunotherapy aims to harness the immune system identify and eliminate cancer cells. However, its full potential is hindered by immunosuppressive nature of tumors. Radiotherapy remains a key treatment modality for local tumor control immunomodulation within microenvironment. Yet, efficacy radiotherapy often limited radiosensitivity, traditional radiosensitizers have shown effectiveness in hepatocellular carcinoma (HCC). To address these challenges, we developed novel multifunctional nanoparticle system, ZIF-8@MnCO@DOX (ZMD), designed enhance drug delivery tissues. In microenvironment, Zn²⁺ Mn²⁺ ions released from ZMD participate Fenton-like reaction, generating reactive oxygen species (ROS) that promote cell death improve radiosensitivity. Additionally, release doxorubicin (DOX)-an anthracycline chemotherapeutic agent-induces DNA damage apoptosis The combined action metal double-stranded (dsDNA) damaged cells synergistically activates cyclic GMP-AMP synthase (cGAS)-stimulator interferon genes (STING) pathway, thereby initiating robust anti-tumor response. Both vitro vivo experiments demonstrated effectively cGAS-STING promotes responses, exerts potent tumor-killing effect combination with radiotherapy, leading regression both primary tumors distant metastases. Our work provides straightforward, safe, effective strategy combining treat advanced cancer.

Язык: Английский

Процитировано

0